Navigation Links
Bacterin Sponsors the 2012 Donate Life Rose Parade Float in Recognition of Donor Families
Date:10/28/2011

BOZEMAN and BELGRADE, Mont., Oct. 28, 2011 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, is sponsoring the 2012 Donate Life Rose Parade® Float entitled "...One More Day."

Bacterin and one of its procurement partners are sponsoring a donor family to attend the Rose Parade and will be recognized as one of the florographs that will be represented on the float.

Donate Life's ninth Rose Parade float entry carries 28 riders, 72 memorial 'florograph' portraits, and thousands of roses carrying personal messages of love, hope and remembrance. The float is designed to represent deceased organ, eye and tissue donors, living donors, and transplant recipients, reminding us all to make every day count and to increase donor awareness. The gift of donation can add years and quality of life to those in need of transplants.  

"We are proud to be a contributing partner and are privileged this year to have one of our organ donor portraits included on the float," said Guy Cook, Bacterin chairman and CEO. "Given the addition of four new recovery partners in recent months, we have an extended need for increasing the outreach and support for our partners and the donor families. The Donate Life Rose Parade Float is an ideal platform for recognizing the selfless gift of donation, and we look forward to continuing our sponsorship."

The float is supported by 60 official partners from across the nation, including organ and tissue recovery organizations, tissue banks, state donor registries, transplant centers and affiliated organizations. The 123rd Rose Parade, themed "Just Imagine," will take place Monday, January 2, 2012 at 10:00 a.m., featuring majestic floral floats, high-stepping equestrian units and spirited marching bands.

About Donate Life

Donate Life is a national brand for donation supported by national organizations and state teams dedicated to motivating the American public to register now as organ, eye and tissue donors. Hundreds of thousands of people from all walks of life in every corner of the country are in need of life-saving and healing gifts that are possible only through organ, eye and tissue. The Donate Life Rose Parade Float national campaign is coordinated by OneLegacy, the non-profit, federally designated organ and tissue recovery agency serving the seven-county greater Los Angeles area, and is supported by more than 100 official sponsors nationwide, including organ and tissue recovery organizations, tissue banks, state donor registries, transplant centers, hospitals, funeral homes and affiliated organizations. Joining OneLegacy as top-level benefactors are the Dignity Memorial® network, North America's largest network of funeral, cremation and cemetery service providers; the American Association of Tissue Banks (AATB); Donate Life America; and the United Network for Organ Sharing (UNOS) and the National Donor Memorial.

For more information about the Donate Life Rose Parade Float, visit the official float website at www.donatelifefloat.org. To learn how to register to become an organ and tissue donor visit www.donatelifetoday.com.

About Bacterin International Holdings

Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.

Bacterin's Medical Device division develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin's strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination. For further information, please visit www.bacterin.com.

Investor Relations:
Liolios Group, Inc.
Scott Liolios or Ron Both
Tel 949-574-3860
info@liolios.com


'/>"/>
SOURCE Bacterin International Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Bacterin International to Present at Stifel Nicolaus 2011 Healthcare Conference on September 8, 2011
2. Bacterin Reports New Hires and Management Reorganization, Driving Most Active Processing Month in July
3. Bacterin International Signs Its Second National GPO Contract for Bacterin Biologics and Its First For Wound Drains with ROi
4. Bacterin International to Present at Noble Financial Capital Markets Seventh Annual Equity Conference on May 16, 2011
5. Bacterin International Secures $1.9 million in Private Placement
6. Bacterin International Updates Fourth Quarter and Full Year 2010 Financial Results
7. Bacterin International Signs LOI to Acquire Assets of Robinson MedSurg LLC
8. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
9. Bacterin International Reconstitutes Its Board of Directors and Appoints Experienced Legal and Financial Professionals
10. Bacterin International Appoints Three New Members to Its Board of Directors
11. Sermo, Inc. Introduces New Sponsorship Product for Pharma, Biotech and Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand ... Excellence in Volunteer Experience from US2020. , US2020’s mission is to change the ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
Breaking Biology Technology:
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):